LLOVET, JM. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008, 359, 378-390
CHENG, AL. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma : a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2009, 10, 25-34
KUDO, M. Positioning of a moleculartargeted agent, sorafenib, in the treatment algorithm for hepatocellular carcinoma and implication of many complete remission cases in Japan. Oncology. 2010, 78, 154-166